Our Intercept technology can also improve donor eligibility by alleviating the need for certain donor deferrals, like travel-related deferrals designed to minimize the risk of malaria transmission.

Aug 3, 2021 / CEO / receipt, needs a key / Obie Greenman, CEO | earnings call 2021-08-03 | transcript 2eb9a059-8521-4c93-a786-966a728539ba | chars 8621-8818 | segment 8